Alnylam Pharmaceuticals Inc (ALNY)
153.77
+2.53
(+1.67%)
USD |
NASDAQ |
May 07, 14:06
Alnylam Pharmaceuticals Debt to Equity Ratio: -4.660 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2024 | -4.660 |
| December 31, 2023 | -4.626 |
| September 30, 2023 | -6.148 |
| June 30, 2023 | -2.496 |
| March 31, 2023 | -3.926 |
| December 31, 2022 | -6.427 |
| September 30, 2022 | -15.02 |
| June 30, 2022 | 3.850 |
| March 31, 2022 | 1.687 |
| December 31, 2021 | 1.149 |
| September 30, 2021 | 0.5739 |
| June 30, 2021 | 0.5076 |
| March 31, 2021 | 0.2069 |
| December 31, 2020 | 0.1882 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.0171 |
| March 31, 2019 | 0.0194 |
| December 31, 2018 | 0.023 |
| September 30, 2018 | 0.0203 |
| June 30, 2018 | 0.0185 |
| March 31, 2018 | 0.0171 |
| Date | Value |
|---|---|
| December 31, 2017 | 0.017 |
| September 30, 2017 | 0.1417 |
| June 30, 2017 | 0.1336 |
| March 31, 2017 | 0.1805 |
| December 31, 2016 | 0.163 |
| September 30, 2016 | 0.1478 |
| June 30, 2016 | 0.1366 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-15.02
Minimum
Sep 2022
3.850
Maximum
Jun 2022
-1.756
Average
--
Median
Sep 2019
Debt to Equity Ratio Benchmarks
| Ionis Pharmaceuticals Inc | 3.317 |
| Pfizer Inc | 0.7959 |
| Blueprint Medicines Corp | 0.7705 |
| BridgeBio Pharma Inc | -1.635 |
| Madrigal Pharmaceuticals Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 3.824B |
| Total Liabilities (Quarterly) | 4.044B |
| Shareholders Equity (Quarterly) | -219.27M |
| Current Ratio | 3.174 |
| Net Debt Paydown Yield | -0.01% |